Perceived Benefits of Treatments of Alzheimer’s Disease and Related Dementias for Cost-Effectiveness Estimates
2024

Understanding the Benefits of Alzheimer's Treatments

Sample size: 12 publication

Author Information

Author(s): Zanjani Faika, McIntyre Madeline, Gendron Tracey, van den Broek-Altenburg Eline

Primary Institution: Virginia Commonwealth University

Hypothesis

Which non-QALY benefits of Alzheimer’s Disease and Related Dementia treatments are most important?

Conclusion

Important elements like hope and option value are often overlooked in cost-effectiveness estimates for Alzheimer's treatments.

Supporting Evidence

  • Participants lacked knowledge about Alzheimer's and its treatments.
  • Cost and side effects were important considerations for treatment.
  • Participants felt the healthcare system was confusing and uncoordinated.
  • Emotional impacts of Alzheimer's included grief, sadness, and hopelessness.

Takeaway

This study looked at what people think is important about Alzheimer's treatments, and found that feelings like hope are often ignored when deciding if a treatment is worth it.

Methodology

Twelve semi-structured focus groups were conducted with at-risk individuals and caregivers, analyzed thematically.

Potential Biases

Participants may have biases due to their personal experiences with the healthcare system.

Limitations

Participants expressed a lack of trust in the healthcare system and faced challenges in accessing care.

Participant Demographics

60% at-risk individuals and 40% caregivers.

Digital Object Identifier (DOI)

10.1093/geroni/igae098.3683

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication